期刊
NANOSCALE
卷 7, 期 6, 页码 2336-2351出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4nr04426f
关键词
-
类别
资金
- European project Magnifyco [NMP4-SL-2009-228622]
- Italian AIRC [14527]
- EU-ITN network Mag(net)icFun [PITN-GA-2012-290248]
- Italian FIRB [588 BAP115AYN]
Efficient targeting in tumor therapies is still an open issue: systemic biodistribution and poor specific accumulation of drugs weaken efficacy of treatments. Engineered nanoparticles are expected to bring benefits by allowing specific delivery of drug to the tumor or acting themselves as localized therapeutic agents. In this study we have targeted epithelial ovarian cancer with inorganic nanoparticles conjugated to a human antibody fragment against the folate receptor over-expressed on cancer cells. The conjugation approach is generally applicable. Indeed several types of nanoparticles (either magnetic or fluorescent) were engineered with the fragment, and their biological activity was preserved as demonstrated by biochemical methods in vitro. In vivo studies with mice bearing orthotopic and subcutaneous tumors were performed. Elemental and histological analyses showed that the conjugated magnetic nanoparticles accumulated specifically and were retained at tumor sites longer than the non-conjugated nanoparticles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据